Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Disease flare induced by D-Trp6-LHRH analogue in patients with metastatic prostatic cancer.

× No keyword cloud information.

11 in total

1. The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.

Authors: Luis A Kluth; Shahrokh F Shariat; Christian Kratzik; Scott Tagawa; Guru Sonpavde; Malte Rieken; Douglas S Scherr; Karl Pummer
Journal: World J Urol Date: 2013-09-03 Impact factor: 4.226

2. Defining co-related parameters between 'metabolic' flare and 'clinical', 'biochemical', and 'osteoblastic' flare and establishing guidelines for assessing response to treatment in cancer.

Authors: Sandip Basu; Abass Alavi
Journal: Eur J Nucl Med Mol Imaging Date: 2007-04 Impact factor: 9.236

3. Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations.

Authors: F Labrie; A Dupont; A Belanger; R Lachance; M Giguere
Journal: Br Med J (Clin Res Ed) Date: 1985-08-10

Review 4. Disease flare with gonadotrophin-releasing hormone (GnRH) analogues. How serious is it?

Authors: R Scaletscky; J A Smith
Journal: Drug Saf Date: 1993-04 Impact factor: 5.606

Review 5. Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience.

Authors: F Labrie; A Dupont; A Bélanger; L Cusan; M Giguère; Y Lacourcière; I Luthy; D Bégin; C Labrie; J Simard
Journal: Cancer Metastasis Rev Date: 1987 Impact factor: 9.264

6. Flare Associated with LHRH-Agonist Therapy.

Authors: I M Thompson
Journal: Rev Urol Date: 2001

7. Challenges with luteinizing hormone-releasing hormone agonists: flare and surge.

Authors: Michael K Brawer
Journal: Rev Urol Date: 2004

8. Androgen deprivation therapy: a cornerstone in the treatment of advanced prostate cancer.

Authors: Michael K Brawer
Journal: Rev Urol Date: 2004

Review 9. GnRH agonists and antagonists. Current clinical status.

Authors: M Filicori; C Flamigni
Journal: Drugs Date: 1988-01 Impact factor: 9.546

10. Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer.

Authors: T J Perren; R N Clayton; G Blackledge; L C Bailey; G Holder; S S Lynch; D G Arkell; J Cottam; D Farrar; C H Young
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333